http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100944034-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100944034-B1 |
titleOfInvention | Oral Dosage Forms of Protease-Resistant Polypeptides |
abstract | An oral dosage form of a therapeutic polypeptide that is protease resistant is provided. Dosage dosages administered per day or week are greater than subcutaneous dosages. Oral dosage forms also include tablets and capsules such as enteric-coated formulations. Also provided are methods of treating or preventing a disease or condition that can be treated or prevented by administering an oral dosage form of a protease resistant polypeptide.n n n n Proteases, oral administration, enteric-coated formulations, protease resistance |
priorityDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 8301.